314 related articles for article (PubMed ID: 14646378)
1. Injection immunotherapy with different airborne allergens did not prevent de novo sensitization to ragweed and birch pollen north of Milan.
Asero R
Int Arch Allergy Immunol; 2004 Jan; 133(1):49-54. PubMed ID: 14646378
[TBL] [Abstract][Full Text] [Related]
2. Analysis of new respiratory allergies in patients monosensitized to airborne allergens in the area north of Milan.
Asero R
J Investig Allergol Clin Immunol; 2004; 14(3):208-13. PubMed ID: 15552714
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of injection immunotherapy with ragweed and birch pollen in elderly patients.
Asero R
Int Arch Allergy Immunol; 2004 Dec; 135(4):332-5. PubMed ID: 15564775
[TBL] [Abstract][Full Text] [Related]
4. Birch and ragweed pollinosis north of Milan: a model to investigate the effects of exposure to "new" airborne allergens.
Asero R
Allergy; 2002 Nov; 57(11):1063-6. PubMed ID: 12359005
[TBL] [Abstract][Full Text] [Related]
5. Urticaria is associated with birch-pollen sensitization.
Hesselmar B; Eriksson B; Aberg N
Pediatr Allergy Immunol; 2007 Dec; 18(8):692-5. PubMed ID: 17651384
[TBL] [Abstract][Full Text] [Related]
6. Potential health risk of allergenic pollen with climate change associated spreading capacity: Ragweed and olive sensitization in two German federal states.
Höflich C; Balakirski G; Hajdu Z; Baron JM; Kaiser L; Czaja K; Merk HF; Gerdsen S; Strassen U; Bas M; Bier H; Dott W; Mücke HG; Straff W; Chaker A; Röseler S
Int J Hyg Environ Health; 2016 May; 219(3):252-60. PubMed ID: 26906017
[TBL] [Abstract][Full Text] [Related]
7. Pollen specific immunotherapy is not a risk factor for de novo sensitization to cross-reacting allergens in monosensitized subjects.
Asero R
J Investig Allergol Clin Immunol; 2006; 16(4):253-7. PubMed ID: 16889283
[TBL] [Abstract][Full Text] [Related]
8. Features of sensitization to airborne allergens among extra-European immigrants living in 2 distinct areas of Northern Italy.
Asero R; Conte M; Senna GE
Eur Ann Allergy Clin Immunol; 2012 Jun; 44(3):107-12. PubMed ID: 22905591
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
Rossi RE; Monasterolo G
Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
[TBL] [Abstract][Full Text] [Related]
10. Effect of tree pollen specific, subcutaneous immunotherapy on the oral allergy syndrome to apple and hazelnut.
Bucher X; Pichler WJ; Dahinden CA; Helbling A
Allergy; 2004 Dec; 59(12):1272-6. PubMed ID: 15507095
[TBL] [Abstract][Full Text] [Related]
11. Artemisia and Ambrosia hypersensitivity: co-sensitization or co-recognition?
Asero R; Wopfner N; Gruber P; Gadermaier G; Ferreira F
Clin Exp Allergy; 2006 May; 36(5):658-65. PubMed ID: 16650052
[TBL] [Abstract][Full Text] [Related]
12. How long does the effect of birch pollen injection SIT on apple allergy last?
Asero R
Allergy; 2003 May; 58(5):435-8. PubMed ID: 12752332
[TBL] [Abstract][Full Text] [Related]
13. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
[TBL] [Abstract][Full Text] [Related]
14. Ragweed allergy in northern Italy: are patterns of sensitization changing?
Asero R
Eur Ann Allergy Clin Immunol; 2012 Aug; 44(4):157-9. PubMed ID: 23092001
[TBL] [Abstract][Full Text] [Related]
15. Sensitization to common ragweed in southern Bavaria: clinical and geographical risk factors in atopic patients.
Ruëff F; Przybilla B; Walker A; Gmeiner J; Kramer M; Sabanés-Bové D; Küchenhoff H; Herzinger T
Int Arch Allergy Immunol; 2012; 159(1):65-74. PubMed ID: 22572962
[TBL] [Abstract][Full Text] [Related]
16. [Sensitization to airborne ragweed pollen--a cause of allergic respiratory diseases in Germany?].
Boehme MW; Gabrio T; Dierkesmann R; Felder-Kennel A; Flicker-Klein A; Joggerst B; Kersting G; König M; Link B; Maisner V; Wetzig J; Weidner U; Behrendt H
Dtsch Med Wochenschr; 2009 Jul; 134(28-29):1457-63. PubMed ID: 19572244
[TBL] [Abstract][Full Text] [Related]
17. Sensitization profiles in birch pollen-allergic patients with and without oral allergy syndrome to apple: lessons from multiplexed component-resolved allergy diagnosis.
Ebo DG; Bridts CH; Verweij MM; De Knop KJ; Hagendorens MM; De Clerck LS; Stevens WJ
Clin Exp Allergy; 2010 Feb; 40(2):339-47. PubMed ID: 19709127
[TBL] [Abstract][Full Text] [Related]
18. A follow-up study of immunotherapy-treated birch-allergic patients: effect on the expression of chemokines in the nasal mucosa.
Plewako H; Holmberg K; Oancea I; Gotlib T; Samoliński B; Rak S
Clin Exp Allergy; 2008 Jul; 38(7):1124-31. PubMed ID: 18691293
[TBL] [Abstract][Full Text] [Related]
19. [Development of new sensitizations to allergic components in birch pollen extract during specific immunotherapy].
Modrzyński M; Zawisza E
Przegl Lek; 2003; 60(3):130-2. PubMed ID: 14575011
[TBL] [Abstract][Full Text] [Related]
20. Geographical variation in the prevalence of positive skin tests to environmental aeroallergens in the European Community Respiratory Health Survey I.
Bousquet PJ; Chinn S; Janson C; Kogevinas M; Burney P; Jarvis D;
Allergy; 2007 Mar; 62(3):301-9. PubMed ID: 17298348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
